IL22 and clostridium difficile infection: Additionally, the intestinal microbiome has been shown to affect the production of cytokines, such as IL-25 (Buonomo et al., 2016) and IL-22 (Nagao-Kitamoto et al., 2020), which can ultimately alter CDI outcomes.